Selenium is to thyroid hormone what a spark plug is to an engine — a small component that makes the entire system work. The thyroid gland contains the highest selenium concentration of any organ in the human body, and for good reason: selenium is a component of the deiodinase enzymes that convert the storage form of thyroid hormone (T4) into the active form (T3). Without selenium, this conversion stops, and even with adequate T4 from medication or production, the body cannot activate it.
The Deiodinase Enzyme Family
Three deiodinase enzymes control thyroid hormone activation and inactivation throughout the body. Type 1 deiodinase (DIO1) in the liver and kidney converts T4 to T3. Type 2 deiodinase (DIO2) in the brain, pituitary, and brown adipose tissue performs the same conversion locally, maintaining T3 levels in critical tissues even when systemic T3 is low. Type 3 deiodinase (DIO3) inactivates T4 and T3, acting as a counterbalance that prevents thyroid hormone excess. All three enzymes require selenocysteine — the 21st amino acid, incorporated cotranslationally at a specific UGA codon — as their active site. Selenium is the essential cofactor that makes this incorporation possible.
In selenium deficiency, the deiodinases with the lowest priority for selenium incorporation are preferentially impaired — typically DIO1 in the liver. This is why selenium-deficient individuals can have normal TSH and T4 but low T3, a pattern sometimes called “low T3 syndrome.” The body is conserving T3 by reducing its conversion from T4 in the liver, preserving active thyroid hormone for the brain and heart, where DIO2 continues to function.
Selenium and Hashimoto’s Thyroiditis
Hashimoto’s — autoimmune destruction of the thyroid gland — is the most common cause of hypothyroidism in developed countries. Selenium supplementation in Hashimoto’s patients consistently reduces anti-thyroid peroxidase (anti-TPO) antibody titres. A 2019 meta-analysis of 14 randomised controlled trials found that selenium supplementation reduced anti-TPO antibodies by approximately 30% compared to placebo, with greater effects in patients with higher baseline antibody levels. The proposed mechanism is selenium’s role in reducing the oxidative stress that accelerates autoimmune thyroid destruction.
Selenium also reduces the inflammatory damage from thyroid peroxidase (TPO) oxidation reactions. TPO generates hydrogen peroxide as part of its catalytic cycle. Without adequate selenium-dependent glutathione peroxidase activity to neutralise this H2O2, the thyroid gland experiences oxidative damage that amplifies the autoimmune response. Selenium supplementation restores this neutralisation capacity.
Brazil Nuts: The Most Reliable Dietary Source
Brazil nuts contain selenium in the form of selenomethionine, which is highly bioavailable and requires no additional digestion for absorption. A single Brazil nut contains approximately 68-91mcg of selenium — more than the RDA of 55mcg and below the UL of 400mcg. Two to three Brazil nuts daily is sufficient to maintain optimal selenium status for most people. The variability in Brazil nut selenium content is significant — it depends on the selenium content of the soil where the trees grow — but even one Brazil nut daily provides meaningful supplementation.
For people with Hashimoto’s or subclinical hypothyroidism with elevated antibodies, 200mcg of selenomethionine daily is a evidence-based dose that has shown consistent benefits in clinical trials without approaching the toxicity threshold. Selenomethionine is the preferred form because it is incorporated into body proteins non-specifically, providing a slow-release selenium pool that is not subject to the narrow homeostatic controls that regulate other selenium compounds.
Selenium and Cancer Prevention
Selenium’s role in cancer prevention was suggested by epidemiological studies showing inverse correlations between selenium intake and cancer mortality in regions with low soil selenium. The NPC (Nutritional Prevention of Cancer) trial in the 1990s found that 200mcg of selenised yeast daily reduced total cancer incidence by 37% and reduced cancer mortality by 50% compared to placebo. However, the SELECT trial — a larger RCT of selenium supplementation in healthy men — found no benefit for prostate cancer prevention, possibly because the trial population was selenium-replete to begin with. The evidence suggests selenium supplementation helps when status is deficient, but provides no additional benefit when status is already adequate.
Selenomethionine vs Sodium Selenite
The two most common supplemental forms are selenomethionine (organic, from selenised yeast) and sodium selenite (inorganic). Selenomethionine is absorbed via methionine transport pathways and incorporated into body protein stores, providing a slow-release mechanism. Comparative trials show selenomethionine raises plasma selenium more effectively than sodium selenite at equivalent doses.
Why Selenium Status Matters for Thyroid Patients
Selenium deficiency impairs both antioxidant defence and thyroid hormone activation. In people with Hashimoto thyroiditis, selenium supplementation at 200mcg per day has been shown to reduce anti-TPO antibodies by approximately 40% in randomised controlled trials, with concurrent reductions in thyroiditis activity. The mechanism involves reduced oxidative stress in the thyroid gland and modulation of the autoimmune response.
Leave a Reply